PROLOPA CAP 50-12.5
Identification of Prolopa Cap 50-12.5
Please sign up for a free trial to see the description of this product.
Examples of the descriptions of OTHER drugs:
Lipitor 10 mg
Apo-Irbesartan 150 mg
Crestor 20 mg
Google image searchProduct monograph
Active ingredients
levodopa, 50 MG
benserazide (benserazide hydrochloride), 12.5 MG
DIN: 00522597
Dosage form(s): CAPSULE
Route(s) of administration: ORAL
Schedule: Prescription
Company: HOFFMANN-LA ROCHE LIMITED
Date: 31-DEC-1981
ATC:
- N04 — ANTI-PARKINSON DRUGS (ATC, ATC/DDD, )
- N04B — DOPAMINERGIC AGENTS (ATC, ATC/DDD)
- N04BA — Dopa and dopa derivatives (ATC, ATC/DDD)
- N04BA02 — LEVODOPA AND DECARBOXYLASE INHIBITOR (ATC/DDD)
Reference brand drug: Sinemet
Pharmaceutical standard: MFR
External Links for Prolopa Cap 50-12.5
Search on Google
- Prolopa Cap 50-12.5 side effects
- Prolopa Cap 50-12.5 dosage
- levodopa side effects
- levodopa dosage
- benserazide side effects
- benserazide dosage
Hoffmann-La Roche Limited
Go to Hoffmann-La Roche website to see drug product details. Sometimes you can find prolopa cap 50-12.5 photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.
